YU6396A - Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija - Google Patents

Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija

Info

Publication number
YU6396A
YU6396A YU6396A YU6396A YU6396A YU 6396 A YU6396 A YU 6396A YU 6396 A YU6396 A YU 6396A YU 6396 A YU6396 A YU 6396A YU 6396 A YU6396 A YU 6396A
Authority
YU
Yugoslavia
Prior art keywords
hiv
combination
compounds
protease inhibitor
hiv infection
Prior art date
Application number
YU6396A
Other languages
English (en)
Other versions
YU49417B (sh
Inventor
Jereffey A. Chodakewitz
Emilio A. Emini
Original Assignee
Merck & Co.Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co.Inc. filed Critical Merck & Co.Inc.
Publication of YU6396A publication Critical patent/YU6396A/sh
Publication of YU49417B publication Critical patent/YU49417B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Kombinacija inhibitora HIV proteaze jedinjenja J formule: 3TC, i opciono AZT, ddl, ili ddc je korisna u inhibiciji HIV proteaze, inhibiciji HIV reverzne transkriptaze, prevenciji ili tretiranju infekcije HIV-om i tretiranju SIDE, ili kao jedinjenja, farmaceutski prihvatljive soli, komponente farmaceutske kompozicije, bilo ili ne u kombinaciji sa drugim antivirusnim sredstvima, imunomodlatorima, antibioticima ili vakcinama. Takodje su opisani postupci za tretiranje SIDE i postupci za prevenciju ili tretiranje infekcije HIV-om.
YU6396A 1995-02-01 1996-02-01 Terapijska kombinacija za hiv infekcije YU49417B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/382,113 US6689761B1 (en) 1995-02-01 1995-02-01 Combination therapy for HIV infection

Publications (2)

Publication Number Publication Date
YU6396A true YU6396A (sh) 1999-06-15
YU49417B YU49417B (sh) 2006-01-16

Family

ID=23507574

Family Applications (1)

Application Number Title Priority Date Filing Date
YU6396A YU49417B (sh) 1995-02-01 1996-02-01 Terapijska kombinacija za hiv infekcije

Country Status (38)

Country Link
US (1) US6689761B1 (sh)
EP (1) EP0806957B1 (sh)
JP (1) JPH10513186A (sh)
KR (1) KR19980701856A (sh)
CN (1) CN1160081C (sh)
AR (1) AR002957A1 (sh)
AT (1) ATE243519T1 (sh)
AU (1) AU711176B2 (sh)
BR (1) BR9607714A (sh)
CA (1) CA2211973A1 (sh)
CO (1) CO4700430A1 (sh)
CZ (1) CZ244497A3 (sh)
DE (1) DE69628819T2 (sh)
DK (1) DK0806957T3 (sh)
DZ (1) DZ1988A1 (sh)
EA (1) EA000437B1 (sh)
EE (1) EE03514B1 (sh)
ES (1) ES2200052T3 (sh)
FI (1) FI973184A (sh)
HK (1) HK1004659A1 (sh)
HR (1) HRP960045B1 (sh)
HU (1) HUP9800810A3 (sh)
IL (1) IL116925A (sh)
IS (1) IS1970B (sh)
MX (1) MX9705916A (sh)
MY (1) MY121604A (sh)
NO (1) NO314568B1 (sh)
NZ (1) NZ302153A (sh)
PE (1) PE38397A1 (sh)
PL (1) PL182742B1 (sh)
PT (1) PT806957E (sh)
SA (1) SA96160669B1 (sh)
SK (1) SK103797A3 (sh)
TR (1) TR199700735T1 (sh)
TW (1) TW442291B (sh)
WO (1) WO1996023509A1 (sh)
YU (1) YU49417B (sh)
ZA (1) ZA96722B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008539A1 (en) * 1996-08-26 1998-03-05 Chiron Corporation Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU6761198A (en) * 1998-03-17 1999-10-11 Julianna Lisziwiewicz Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
JP5033303B2 (ja) 2001-07-05 2012-09-26 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗原性ｃ型ｈｉｖポリペプチドをコードするポリヌクレオチド、ポリペプチドおよびそれらの使用
EP1814548A1 (en) * 2004-11-19 2007-08-08 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and reverset
US7745455B2 (en) 2005-07-27 2010-06-29 Emil Toma Zalcitabine (ddC) boosted lamivudine (3TC) compositions for antiretroviral therapy
EP3565554A4 (en) * 2017-01-04 2020-08-19 Oyagen, Inc. COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IL100502A (en) 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
KR100311551B1 (ko) 1993-03-31 2001-12-28 폴락 돈나 엘. Aids 치료용 약제학적 배합물 중의 hiv 프로테아제 억제제
IL114208A0 (en) 1994-06-27 1995-10-31 Merck & Co Inc Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors

Also Published As

Publication number Publication date
EE9700165A (et) 1998-02-16
BR9607714A (pt) 1998-01-13
EP0806957B1 (en) 2003-06-25
DE69628819D1 (de) 2003-07-31
CO4700430A1 (es) 1998-12-29
IS4533A (is) 1997-07-29
EA000437B1 (ru) 1999-08-26
CA2211973A1 (en) 1996-08-08
HK1004659A1 (en) 1998-12-04
SK103797A3 (en) 1998-02-04
JPH10513186A (ja) 1998-12-15
ES2200052T3 (es) 2004-03-01
SA96160669B1 (ar) 2006-07-30
CZ244497A3 (cs) 1998-01-14
IS1970B (is) 2004-12-15
HRP960045B1 (en) 2004-06-30
FI973184A0 (fi) 1997-07-31
AR002957A1 (es) 1998-05-27
TR199700735T1 (xx) 1998-02-21
PE38397A1 (es) 1997-10-09
CN1179722A (zh) 1998-04-22
DE69628819T2 (de) 2004-05-13
US6689761B1 (en) 2004-02-10
AU711176B2 (en) 1999-10-07
IL116925A (en) 2000-07-26
ZA96722B (en) 1996-08-26
WO1996023509A1 (en) 1996-08-08
MY121604A (en) 2006-02-28
IL116925A0 (en) 1996-05-14
NO314568B1 (no) 2003-04-14
KR19980701856A (ko) 1998-06-25
EE03514B1 (et) 2001-10-15
HRP960045A2 (en) 1997-10-31
AU4774896A (en) 1996-08-21
ATE243519T1 (de) 2003-07-15
HUP9800810A2 (hu) 1998-07-28
DK0806957T3 (da) 2003-09-29
EA199700150A1 (ru) 1997-12-30
FI973184A (fi) 1997-09-30
NO973533L (no) 1997-10-01
NO973533D0 (no) 1997-07-31
MX9705916A (es) 1997-10-31
PL182742B1 (pl) 2002-02-28
CN1160081C (zh) 2004-08-04
DZ1988A1 (fr) 2002-07-20
EP0806957A1 (en) 1997-11-19
HUP9800810A3 (en) 2001-05-28
NZ302153A (en) 1998-12-23
YU49417B (sh) 2006-01-16
PT806957E (pt) 2003-10-31
TW442291B (en) 2001-06-23
PL321660A1 (en) 1997-12-22

Similar Documents

Publication Publication Date Title
DE60036961D1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1-piperazinpentanamide als hiv-proteasehemmer
ME00427B (me) N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze
DE60218511D1 (de) Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase
EA200300449A1 (ru) Аза- и полиаза-нафталинилкарбоксамиды, полезные в качестве ингибиторов вич-интегразы
MXPA04006553A (es) Compuesto de 4-oxoquinolina y uso del mismo como inhibidor de integrasa de vih.
ES2178037T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen.
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
YU172991A (sh) Sinergizam inhibitora hiv reverzne transkriptaze
ATE215952T1 (de) Hiv-proteaseinhibitoren
YU6396A (sh) Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
DE60322919D1 (de) 8-hydroxy-1-oxotetrahydropyrrolopyrazinverbindungen, die sich als inhibitoren von hiv-integrase eignen
EA200000513A1 (ru) Комбинированная терапия для лечения спид
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
DK0774969T3 (da) HIV-proteaseinhibitor kombination
DK0728002T3 (da) Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner
KR970703770A (ko) 사람 면역결핍 바이러스 감염에 대한 배합 치료(Combination therapy for HIV infection)
ATE268768T1 (de) Antithrombosemittel
DK0728001T3 (da) Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 6-infektioner
YU231590A (sh) Derivati aminokiselina